Jo H. M. Berden

11.1k citations

176 papers · 7.8k indexed · h-index 54

Nephrology top 0.1%
- Renal Diseases and Glomerulopathies 50
Rheumatology top 0.2%
- Systemic Lupus Erythematosus Research 58
Immunology top 0.5%
- T-cell and B-cell Immunology 21
Immunology and Allergy top 1%
- Cell Adhesion Molecules Research 25
Cell Biology top 1%
- Proteoglycans and glycosaminoglycans research 41
Hematology
- Platelet Disorders and Treatments 28
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 19
Molecular Biology
- Glycosylation and Glycoproteins Research 17

Co-authors: Johan van der Vlag Angelique L. Rops Marinka A.H. Bakker Henry Dijkman Jürgen Dieker Toin H. Van Kuppevelt Jack F.M. Wetzels W.J.M. Tax
Cited by: Nephrology Rheumatology Immunology
Journals: The Lancet (1 paper)Journal of Biological Chemistry (6 papers)Journal of Clinical Investigation (1 paper)
Partner nations: Netherlands United States Germany

In The Last Decade

Jo H. M. Berden

176 papers receiving 7.6k citations

Peers

Countries citing papers authored by Jo H. M. Berden

Since Specialization

Citations

This map shows the geographic impact of Jo H. M. Berden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo H. M. Berden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo H. M. Berden more than expected).

Fields of papers citing papers by Jo H. M. Berden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo H. M. Berden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo H. M. Berden. The network helps show where Jo H. M. Berden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jo H. M. Berden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jo H. M. Berden Line = papers co-authored together Jo H. M. Berden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis Frontiers in Molecular Biosciences ·Marissa L. Maciej-Hulme,Jasper J. van Gemst,Patience Sanderson,Angelique L. Rops,Jo H. M. Berden,Bart Smeets,I. Jonathan Amster,Ton J. Rabelink,Johan van der Vlag	2023	2
2	Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis PLoS ONE ·Jasper J. van Gemst,Nathalie J. H. G. Passmann,Angelique L. Rops,Toin H. Van Kuppevelt,Jo H. M. Berden,Markus A. Loeven,Ton J. Rabelink,Bart Smeets,Johan van der Vlag	2021	2
3	Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains PLoS ONE ·Jasper J. van Gemst,M. Kouwenberg,Angelique L. Rops,Toin H. Van Kuppevelt,Jo H. M. Berden,Ton J. Rabelink,Markus A. Loeven,Johan van der Vlag	2018	12
4	Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition Arteriosclerosis Thrombosis and Vascular Biology ·Elmar Pieterse,Nils Rother,Marjolein Garsen,Julia M. Hofstra,Simon C. Satchell,Markus Hoffmann,Markus A. Loeven,Hanneke Knaapen,Olivier W.H. van der Heijden,Jo H. M. Berden,Luuk B. Hilbrands,Johan van der Vlag	2017	196
5	Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis American Journal Of Pathology ·Marjolein Garsen,Marilen Benner,Henry Dijkman,Toin H. Van Kuppevelt,Jin‐Ping Li,Ton J. Rabelink,Israël Vlodavsky,Jo H. M. Berden,Angelique L. Rops,Michael Elkin,Johan van der Vlag	2016	51
6	Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte The Journal of Pathology ·Marjolein Garsen,Ramon Sonneveld,Angelique L. Rops,Suzanne Huntink,Toin H. Van Kuppevelt,Ton J. Rabelink,Joost G.J. Hoenderop,Jo H. M. Berden,Tom Nijenhuis,Johan van der Vlag	2015	38
7	Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis. PubMed ·Suzanne Arends,Jo H. M. Berden,Cecile Grootscholten,R. H. W. M. Derksen,Stefan P. Berger,Ruud G.L. de Sévaux,Alexandre E. Voskuyl,M. Bijl	2014	9
8	Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis. PubMed ·A. van Tellingen,Alexandre E. Voskuyl,Marc Vervloet,Marc Bijl,Ruud G.L. de Sévaux,Stefan P. Berger,R. H. W. M. Derksen,Jo H. M. Berden	2012	18
9	The role of dendritic cells in the pathogenesis of systemic lupus erythematosus Arthritis Research & Therapy ·Justin H. Fransen,Johan van der Vlag,Jurjen M. Ruben,Gosse J. Adema,Jo H. M. Berden,Luuk B. Hilbrands	2010	71
10	Anti-proteinuric effects of glycosaminoglycan-based drugs. PubMed ·Tessa J.M. Wijnhoven,Joost F.M. Lensen,Angelique L. Rops,Kevin McCarthy,Johan van der Vlag,Jo H. M. Berden,Lambert P.W.J. van den Heuvel,Toin H. Van Kuppevelt	2007	15
11	Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains Nephrology Dialysis Transplantation ·T. J. Wijnhoven,Joyce Geelen,Marinka A.H. Bakker,Joost F.M. Lensen,Angelique L. Rops,Andrea B. Kramer,G. Navis,M. J. W. van den Hoven,Johan van der Vlag,Jo H. M. Berden,Jack F.M. Wetzels,Lambert P.W.J. van den Heuvel,L.A.H. Monnens,Toin H. Van Kuppevelt	2007	7
12	Induction of Glomerular Heparanase Expression in Rats with Adriamycin Nephropathy Is Regulated by Reactive Oxygen Species and the Renin-Angiotensin System Journal of the American Society of Nephrology ·Andrea B. Kramer,Mabel van den Hoven,Angelique L. Rops,Tessa J.M. Wijnhoven,Lambert van den Heuvel,Joost F.M. Lensen,Toin van Kuppevelt,Harry van Goor,Johan van der Vlag,Gerjan Navis,Jo H. M. Berden	2006	72
13	Aberrant Heparan Sulfate Profile in the Human Diabetic Kidney Offers New Clues for Therapeutic Glycomimetics American Journal of Kidney Diseases ·Tessa J.M. Wijnhoven,Joost F.M. Lensen,Angelique L. Rops,Johan van der Vlag,Svein O. Kolset,Hans‐Jacob Bangstad,Per Pfeffer,M. J. W. van den Hoven,Jo H. M. Berden,Lambert P.W.J. van den Heuvel,Toin H. Van Kuppevelt	2006	32
14	Decreased Glomerular Expression of Agrin in Diabetic Nephropathy and Podocytes, Cultured in High Glucose Medium Nephron Experimental Nephrology ·Benito Yard,Stefan Kahlert,R. Engelleiter,S. Resch,R. Waldherr,Alexander J. Groffen,Lambert P.W.J. van den Heuvel,Jan Van Der Watt Born,Jo H. M. Berden,Stephan Kröger,M. Häfner,Fokko J. van der Woude	2001	34
15	Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane Diabetologia ·J.W. van der Pijl,M. R. Daha,Jacob van den Born,Nicole A.M. Verhagen,H. H. P. J. Lemkes,Richard Bucala,Jo H. M. Berden,A. H. Zwinderman,Jan A. Bruijn,Leendert A. van Es,Fokko J. van der Woude	1998	26
16	Altered Composition of Urinary Heparan Sulfate in Patients With COPD American Journal of Respiratory and Critical Care Medicine ·Chris H.A. van de Lest,Elly M. M. Versteeg,J.H. Veerkamp,Jo H. M. Berden,Jacob van den Born,Leo Heunks,J.-W.J. Lammers,C L van Herwaarden,P. N. Richard Dekhuijzen,Toin H. Van Kuppevelt	1996	12
17	Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy Diabetologia ·L.D. Elving,Jack F.M. Wetzels,Henk J.J. van Lier,E. de Nobel,Jo H. M. Berden	1994	40
18	Production and characterization of a monoclonal antibody against human glomerular heparan sulfate. PubMed ·J. van den Born,Lambertus P. van den Heuvel,Marinka A.H. Bakker,J.H. Veerkamp,Karel J.M. Assmann,Jo H. M. Berden	1991	31
19	Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes Journal of Autoimmunity ·Rose-Marie Termaat,Kees Brinkman,F. Van Gompel,Lambert P.W.J. van den Heuvel,Jacques H. Veerkamp,Ruud J.T. Smeenk,Jo H. M. Berden	1990	75
20	Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis? PubMed ·Jo H. M. Berden,Rose-Marie Termaat,Kees Brinkman,R J Smeenk,A. J. G. Swaak,P. Faaber,K.J.M. Assmann,L P van de Heuvel,J.H. Veerkamp	1989	9

About Jo H. M. Berden

Jo H. M. Berden is a scholar working on Nephrology, Immunology and Allergy and Rheumatology, having authored 176 papers that have together received 7.8k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (58 papers), Renal Diseases and Glomerulopathies (50 papers), Proteoglycans and glycosaminoglycans research (41 papers), Platelet Disorders and Treatments (28 papers), Cell Adhesion Molecules Research (25 papers), T-cell and B-cell Immunology (21 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Glycosylation and Glycoproteins Research (17 papers). The work is most often cited by research in Nephrology (2.3k citations), Rheumatology (2.6k citations) and Immunology (2.8k citations). Jo H. M. Berden has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Johan van der Vlag, Angelique L. Rops, Marinka A.H. Bakker, Henry Dijkman, Jürgen Dieker, Toin H. Van Kuppevelt, Jack F.M. Wetzels, W.J.M. Tax, Mieke C.J. van Bruggen and Karel J.M. Assmann. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact